DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Thursday, 22 January 2026

Fanregratinib

Fanregratinib

https://newdrugapprovals.org/2026/01/23/fanregratinib/

Anthony Melvin Crasto AfricurePharma Row2Tech Anax AdvectProc Niper-G


 

Posted by at
Labels:

1 comment:

  1. VKraf Gifts17 July 2026 at 01:45

    This is an interesting overview of fanregratinib, an investigational small-molecule drug targeting FGFR1/2/3 pathways. The article highlights the importance of chemical structure and spectroscopy in understanding new therapeutic compounds, especially in oncology research. Advances in targeted therapies like FGFR inhibitors show how medicinal chemistry continues to support the development of more precise treatment approaches.



    Research institutions and scientific events can also benefit from practical branded items such as custom tote bags for carrying research materials, reusable drinkware for laboratories and conferences, and custom stainless steel tumblers for professional gatherings.



    Explore more custom gift ideas at VKraf Gifts or contact 016-3489525.



    Thanks for sharing this informative scientific update and highlighting the connection between organic spectroscopy, drug discovery, and modern cancer research.

    ReplyDelete

Subscribe to: Post Comments (Atom)